These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 520666)

  • 1. Poliomyelitis vaccination benefits--versus risk.
    Assaad F
    Dev Biol Stand; 1979; 43():141-50. PubMed ID: 520666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine control of poliomyelitis in the 1980s.
    Sabin AB
    Yale J Biol Med; 1982; 55(3-4):383-9. PubMed ID: 7180028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantages and disadvantages of killed and live poliomyelitis vaccines.
    Melnick JL
    Bull World Health Organ; 1978; 56(1):21-38. PubMed ID: 307445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after.
    Lasch EE; Abed Y; Marcus O; Gerichter CB; Melnick JL
    Dev Biol Stand; 1986; 65():137-43. PubMed ID: 3556771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk management in a polio-free world.
    Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
    Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poliomyelitis vaccines in Belgium: 20 years of experience.
    Andre FE
    Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
    [No Abstract]   [Full Text] [Related]  

  • 13. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination against poliomyelitis in economically underdeveloped countries.
    Sabin AB
    Bull World Health Organ; 1980; 58(1):141-57. PubMed ID: 6966544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?].
    Fescharek R; Arras-Reiter C; Arens ER; Quast U; Maass G
    Wien Med Wochenschr; 1997; 147(19-20):456-61. PubMed ID: 9471843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Problems of prevention and control of poliomyelitis in Poland].
    Mazurowska-Magdzik W; Bucholc B; Janaszek-Seydlitz W; Szkoda T; Magdzik W
    Przegl Epidemiol; 2010; 64(3):341-7. PubMed ID: 20976944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paralytic poliomyelitis--United States, 1980-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.
    Tebbens RJ; Pallansch MA; Kew OM; Cáceres VM; Jafari H; Cochi SL; Sutter RW; Aylward RB; Thompson KM
    Risk Anal; 2006 Dec; 26(6):1471-505. PubMed ID: 17184393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polio endgame. Polio: The final assault?
    Roberts L
    Science; 2004 Mar; 303(5666):1960-8. PubMed ID: 15044779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.